These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 15257184)

  • 1. N-terminal pro-brain natriuretic peptide predicts cardiovascular events in patients with hypertension and left ventricular hypertrophy: a LIFE study.
    Olsen MH; Wachtell K; Tuxen C; Fossum E; Bang LE; Hall C; Ibsen H; Rokkedal J; Devereux RB; Hildebrandt P
    J Hypertens; 2004 Aug; 22(8):1597-604. PubMed ID: 15257184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-terminal brain natriuretic peptide predicted cardiovascular events stronger than high-sensitivity C-reactive protein in hypertension: a LIFE substudy.
    Olsen MH; Wachtell K; Nielsen OW; Hall C; Wergeland R; Ibsen H; Kjeldsen SE; Devereux RB; Dahlöf B; Hildebrandt PR
    J Hypertens; 2006 Aug; 24(8):1531-9. PubMed ID: 16877955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opposite effects of losartan and atenolol on natriuretic peptides in patients with hypertension and left ventricular hypertrophy: a LIFE substudy.
    Olsen MH; Wachtell K; Tuxen C; Fossum E; Bang LE; Hall C; Ibsen H; Rokkedal J; Devereux RB; Hildebrandt PR
    J Hypertens; 2005 May; 23(5):1083-90. PubMed ID: 15834296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal pro brain natriuretic peptide in arterial hypertension--a marker for left ventricular dimensions and prognosis.
    Hildebrandt P; Boesen M; Olsen M; Wachtell K; Groenning B
    Eur J Heart Fail; 2004 Mar; 6(3):313-7. PubMed ID: 14987582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NT-proBNP and Echocardiographic Parameters for Prediction of Cardiovascular Outcomes in Patients with CKD Stages G2-G4.
    Untersteller K; Girerd N; Duarte K; Rogacev KS; Seiler-Mussler S; Fliser D; Rossignol P; Heine GH
    Clin J Am Soc Nephrol; 2016 Nov; 11(11):1978-1988. PubMed ID: 27515593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-terminal pro-brain natriuretic peptide after myocardial infarction: a marker of cardio-renal function.
    Luchner A; Hengstenberg C; Löwel H; Trawinski J; Baumann M; Riegger GA; Schunkert H; Holmer S
    Hypertension; 2002 Jan; 39(1):99-104. PubMed ID: 11799086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
    Kistorp C; Raymond I; Pedersen F; Gustafsson F; Faber J; Hildebrandt P
    JAMA; 2005 Apr; 293(13):1609-16. PubMed ID: 15811980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal pro-B-type natriuretic peptide for predicting coronary disease and left ventricular hypertrophy in asymptomatic CKD not requiring dialysis.
    DeFilippi CR; Fink JC; Nass CM; Chen H; Christenson R
    Am J Kidney Dis; 2005 Jul; 46(1):35-44. PubMed ID: 15983955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population.
    Olsen MH; Hansen TW; Christensen MK; Gustafsson F; Rasmussen S; Wachtell K; Ibsen H; Torp-Pedersen C; Hildebrandt PR
    Eur Heart J; 2007 Jun; 28(11):1374-81. PubMed ID: 17242007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk assessment in patients with unstable angina/non-ST-elevation myocardial infarction and normal N-terminal pro-brain natriuretic peptide levels by N-terminal pro-atrial natriuretic peptide.
    Jarai R; Iordanova N; Jarai R; Raffetseder A; Woloszczuk W; Gyöngyösi M; Geyer G; Wojta J; Huber K
    Eur Heart J; 2005 Feb; 26(3):250-6. PubMed ID: 15618049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of midregional pro-A-type natriuretic peptide and the N-terminal pro-B-type natriuretic peptide for predicting mortality and cardiovascular events.
    van Hateren KJ; Alkhalaf A; Kleefstra N; Groenier KH; de Jong PE; de Zeeuw D; Gans RO; Struck J; Bilo HJ; Gansevoort RT; Bakker SJ
    Clin Chem; 2012 Jan; 58(1):293-7. PubMed ID: 21948291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of midregional pro-A-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in patients with stable coronary heart disease followed over 8 years.
    Karakas M; Jaensch A; Breitling LP; Brenner H; Koenig W; Rothenbacher D
    Clin Chem; 2014 Nov; 60(11):1441-9. PubMed ID: 25139456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudy.
    Ibsen H; Wachtell K; Olsen MH; Borch-Johnsen K; Lindholm LH; Mogensen CE; Dahlöf B; Devereux RB; de Faire U; Fyhrquist F; Julius S; Kjeldsen SE; Lederballe-Pedersen O; Nieminen MS; Omvik P; Oparil S; Wan Y;
    J Hypertens; 2004 Sep; 22(9):1805-11. PubMed ID: 15311110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term pattern of brain natriuretic peptide and N-terminal pro brain natriuretic peptide and its determinants in the general population: contribution of age, gender, and cardiac and extra-cardiac factors.
    Luchner A; Behrens G; Stritzke J; Markus M; Stark K; Peters A; Meisinger C; Leitzmann M; Hense HW; Schunkert H; Heid IM
    Eur J Heart Fail; 2013 Aug; 15(8):859-67. PubMed ID: 23568644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventricular hypertrophy increases NT-proBNP in subjects with and without hypertension.
    Rivera Otero JM; Taléns-Visconti R; Salvador A; Bertomeu V; Miró V; Jordán A; Sogorb F; Cortés R; Payá R; Diago JL; Grau G;
    Int J Cardiol; 2004 Aug; 96(2):265-71. PubMed ID: 15262044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC
    Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NT-proANP and NT-proBNP circulating levels as predictors of cardiovascular outcome following coronary stent implantation.
    Niccoli G; Conte M; Marchitti S; Montone RA; Fracassi F; Grippo R; Roberto M; Burzotta F; Trani C; Leone AM; Bianchi F; Di Castro S; Volpe M; Crea F; Rubattu S
    Cardiovasc Revasc Med; 2016; 17(3):162-8. PubMed ID: 26987266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma natriuretic peptides and incidence of subtypes of ischemic stroke.
    Berntsson J; Zia E; Borné Y; Melander O; Hedblad B; Engström G
    Cerebrovasc Dis; 2014; 37(6):444-50. PubMed ID: 25060145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aortic valve sclerosis and albuminuria predict cardiovascular events independently in hypertension: a losartan intervention for endpoint-reduction in hypertension (LIFE) substudy.
    Olsen MH; Wachtell K; Bella JN; Palmieri V; Gerdts E; Smith G; Nieminen MS; Dahlöf B; Ibsen H; Devereux RB
    Am J Hypertens; 2005 Nov; 18(11):1430-6. PubMed ID: 16280277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.